The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension
Open accessAbstract
Dysfunctional bone morphogenetic protein receptor-2 (BMPR2) signaling is implicated in the pathogenesis of pulmonary arterial hypertension (PAH). We used a transcriptional high-throughput luciferase reporter assay to screen 3,756 FDA-approved drugs and bioactive compounds for induction of BMPR2 signaling. The best response was achieved with FK506 (tacrolimus), via a dual mechanism of action as a calcineurin inhibitor that also binds FK-binding protein-12 (FKBP12), a repressor of BMP signaling. FK506 released FKBP12 from type I receptors activin receptor-like kinase 1 (ALK1), ALK2, and ALK3 and activated downstream SMAD1/5 and MAPK signaling and ID1 gene regulation in a manner superior to the calcineurin inhibitor cyclosporine and the FKBP12 ligand rapamycin. In pulmonary artery endothelial cells (ECs) from patients with idiopathic PAH, low-dose FK506 reversed dysfunctional BMPR2 signaling. In mice with conditional Bmpr2 deletion in ECs, low-dose FK506 prevented exaggerated chronic hypoxic PAH associated with induction of EC targets of BMP signaling, such as apelin. Low-dose FK506 also reversed severe PAH in rats with medial hypertrophy following monocrotaline and in rats with neointima formation following VEGF receptor blockade and chronic hypoxia. Our studies indicate that low-dose FK506 could be useful in the treatment of PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TGF-β signalling from cell membrane to nucleus through SMAD proteins
Heldin, C.-H., Miyazono, K., & ten Dijke, P. (1997) · Nature · doi:10.1038/37284 · Cited by 3,696
Self-citationCellular and molecular pathobiology of pulmonary arterial hypertension
Humbert, M., Morrell, N. W., Archer, S. L., Stenmark, K. R., MacLean, M. R., Lang, I. M., Christman, B. W., Weir, E. K., Eickelberg, O., Voelkel, N. F., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.029 · Cited by 1,576
Self-citationDeng, Z., Morse, J. H., Slager, S. L., Cuervo, N., Moore, K. J., Venetos, G., Kalachikov, S., Cayanis, E., Fischer, S. G., Barst, R. J., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/303059 · Cited by 1,206
TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4
Nakao, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5353 · Cited by 1,070
TARASEVICIENE‐STEWART, L., KASAHARA, Y., ALGER, L., HIRTH, P., MAHON, G. M., WALTENBERGER, J., VOELKEL, N. F., & TUDER, R. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0343com · Cited by 817
Stenmark, K. R., Meyrick, B., Galie, N., Mooi, W. J., & McMurtry, I. F. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00217.2009 · Cited by 774
Thomson, J. R., Machado, R. D., Pauciulo, M. W., Morgan, N. V., Humbert, M., Elliott, G. C., Ward, K., Yacoub, M., Mikhail, G., Rogers, P., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.10.741 · Cited by 732
Wang, P., & Heitman, J. (2005) · Genome biology · doi:10.1186/gb-2005-6-7-226 · Cited by 715
Atkinson, C., Stewart, S., Upton, P. D., Machado, R., Thomson, J. R., Trembath, R. C., & Morrell, N. W. (2002) · Circulation · doi:10.1161/01.cir.0000012754.72951.3d · Cited by 697
Characterization of Apelin, the Ligand for the APJ Receptor
Lee, D. K., Cheng, R., Nguyen, T., Fan, T., Kariyawasam, A. P., Liu, Y., Osmond, D. H., George, S. R., & O'Dowd, B. F. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740034.x · Cited by 682
Modern Age Pathology of Pulmonary Arterial Hypertension
Stacher, E., Graham, B. B., Hunt, J. M., Gandjeva, A., Groshong, S. D., McLaughlin, V. V., Jessup, M., Grizzle, W. E., Aldred, M. A., Cool, C. D., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0164oc · Cited by 667
Id proteins in development, cell cycle and cancer
Ruzinova, M. B., & Benezra, R. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00147-8 · Cited by 570
Signal transduction by bone morphogenetic proteins
Kawabata, M. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00036-1 · Cited by 528
Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial Hypertension
Abe, K., Toba, M., Alzoubi, A., Ito, M., Fagan, K. A., Cool, C. D., Voelkel, N. F., McMurtry, I. F., & Oka, M. (2010) · Circulation · doi:10.1161/circulationaha.109.927681 · Cited by 510
Brock, M., Trenkmann, M., Gay, R. E., Michel, B. A., Gay, S., Fischler, M., Ulrich, S., Speich, R., & Huber, L. C. (2009) · Circulation Research · doi:10.1161/circresaha.109.197491 · Cited by 465
Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12
Huse, M., Chen, Y.-G., Massagué, J., & Kuriyan, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80555-3 · Cited by 445
The right ventricle in pulmonary hypertension
Chin, K. M., Kim, N. H. S., & Rubin, L. J. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200502000-00003 · Cited by 429
The Immunophilin FKBP12 Functions as a Common Inhibitor of the TGFβ Family Type I Receptors
Wang, T., Li, B.-Y., Danielson, P. D., Shah, P. C., Rockwell, S., Lechleider, R. J., Martin, J., Manganaro, T., & Donahoe, P. K. (1996) · Cell · doi:10.1016/s0092-8674(00)80116-6 · Cited by 388
Masri, F. A., Xu, W., Comhair, S. A. A., Asosingh, K., Koo, M., Vasanji, A., Drazba, J., Anand-Apte, B., & Erzurum, S. C. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00428.2006 · Cited by 376
Hansmann, G., de Jesus Perez, V. A., Alastalo, T.-P., Alvira, C. M., Guignabert, C., Bekker, J. M., Schellong, S., Urashima, T., Wang, L., Morrell, N. W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32503 · Cited by 367
Self-citationBonnet, S., Rochefort, G., Sutendra, G., Archer, S. L., Haromy, A., Webster, L., Hashimoto, K., Bonnet, S. N., & Michelakis, E. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610467104 · Cited by 364
Mechanism of TGFβ receptor inhibition by FKBP12
Chen, Y.-G., Liu, F., & Massagué, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3866 · Cited by 363
Kim, J., Kang, Y., Kojima, Y., Lighthouse, J. K., Hu, X., Aldred, M. A., McLean, D. L., Park, H., Comhair, S. A., Greif, D. M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3040 · Cited by 356
Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis
Chun, H. J., Ali, Z. A., Kojima, Y., Kundu, R. K., Sheikh, A. Y., Agrawal, R., Zheng, L., Leeper, N. J., Pearl, N. E., Patterson, A. J., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34871 · Cited by 329
FKBP Family Proteins: Immunophilins with Versatile Biological Functions
Kang, C. B., Hong, Y., Dhe-Paganon, S., & Yoon, H. S. (2008) · Neurosignals · doi:10.1159/000123041 · Cited by 327
Valdimarsdottir, G., Goumans, M.-J., Rosendahl, A., Brugman, M., Itoh, S., Lebrin, F., Sideras, P., & ten Dijke, P. (2002) · Circulation · doi:10.1161/01.cir.0000033830.36431.46 · Cited by 311
Self-citationRegulatory T Cells Limit Vascular Endothelial Injury and Prevent Pulmonary Hypertension
Tamosiuniene, R., Tian, W., Dhillon, G., Wang, L., Sung, Y. K., Gera, L., Patterson, A. J., Agrawal, R., Rabinovitch, M., Ambler, K., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.236927 · Cited by 306
Self-citationPathobiology of Pulmonary Hypertension
Rabinovitch, M. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.092033 · Cited by 301
Self-citationWest, J., Fagan, K., Steudel, W., Fouty, B., Lane, K., Harral, J., Hoedt-Miller, M., Tada, Y., Ozimek, J., Tuder, R., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000126047.82846.20 · Cited by 263
Alastalo, T.-P., Li, M., de Jesus Perez, V., Pham, D., Sawada, H., Wang, J. K., Koskenvuo, M., Wang, L., Freeman, B. A., Chang, H. Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43382 · Cited by 254
Self-citationHong, K.-H., Lee, Y. J., Lee, E., Park, S. O., Han, C., Beppu, H., Li, E., Raizada, M. K., Bloch, K. D., & Oh, S. P. (2008) · Circulation · doi:10.1161/circulationaha.107.736801 · Cited by 248
Merklinger, S. L., Jones, P. L., Martinez, E. C., & Rabinovitch, M. (2005) · Circulation · doi:10.1161/circulationaha.105.540542 · Cited by 245
Self-citationde Jesus Perez, V. A., Alastalo, T.-P., Wu, J. C., Axelrod, J. D., Cooke, J. P., Amieva, M., & Rabinovitch, M. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200806049 · Cited by 217
Self-citationSmall-molecule displacement of a cryptic degron causes conditional protein degradation
Bonger, K. M., Chen, L.-C., Liu, C. W., & Wandless, T. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.598 · Cited by 206
Self-citationDisruption of the Apelin-APJ System Worsens Hypoxia-Induced Pulmonary Hypertension
Chandra, S. M., Razavi, H., Kim, J., Agrawal, R., Kundu, R. K., de Jesus Perez, V., Zamanian, R. T., Quertermous, T., & Chun, H. J. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.219980 · Cited by 187
Self-citationTargeted gene delivery of BMPR2 attenuates pulmonary hypertension
Reynolds, A. M., Holmes, M. D., Danilov, S. M., & Reynolds, P. N. (2012) · European Respiratory Journal · doi:10.1183/09031936.00187310 · Cited by 186
Chaikuad, A., Alfano, I., Kerr, G., Sanvitale, C. E., Boergermann, J. H., Triffitt, J. T., von Delft, F., Knapp, S., Knaus, P., & Bullock, A. N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365932 · Cited by 180
Somatic Chromosome Abnormalities in the Lungs of Patients with Pulmonary Arterial Hypertension
Aldred, M. A., COMHAIR, S. A. A., Varella‐Garcia, M., Asosingh, K., Xu, W., Noon, G. P., Thistlethwaite, P. A., Tuder, R. M., ERZURUM, S. C., Geraci, M. W., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0491oc · Cited by 158
Sheikh, A. Y., Chun, H. J., Glassford, A. J., Kundu, R. K., Kutschka, I., Ardigò, D., Hendry, S. L., Wagner, R. A., Chen, M. M., Ali, Z. A., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00935.2007 · Cited by 148
Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension
Reynolds, A. M., Xia, W., Holmes, M., Hodge, S. J., Danilov, S. M., Curiel, D. T., Morrell, N. W., & Reynolds, P. N. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00020.2006 · Cited by 147
Morty, R. E., Nejman-Faleńczyk, B., Kwapiszewska, G., Hecker, M., Zakrzewicz, A., Kouri, F. M., Peters, D. M., Dumitrascu, R., Seeger, W., Knaus, P. I., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.141200 · Cited by 145
BMPR2 expression is suppressed by signaling through the estrogen receptor
Austin, E. D., Hamid, R., Hemnes, A. R., Loyd, J. E., Blackwell, T., Yu, C., Phillips, J. A., III, Gaddipati, R., Gladson, S., Gu, E., et al. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-6 · Cited by 128
Penetrance of pulmonary arterial hypertension is modulated by the expression of normalBMPR2allele
Hamid, R., Cogan, J. D., Hedges, L. K., Austin, E. D., Phillips, J. A., Newman, J. H., & Loyd, J. E. (2009) · Human Mutation · doi:10.1002/humu.20922 · Cited by 127
Sinclair, A. M., Göttgens, B., Barton, L. M., Stanley, M. L., Pardanaud, L., Klaine, M., Gering, M., Bahn, S., Sánchez, M. J., Bench, A. J., et al. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9236 · Cited by 105
Paddenberg, R., Stieger, P., von Lilien, A.-L., Faulhammer, P., Goldenberg, A., Tillmanns, H., Kummer, W., & Braun-Dullaeus, R. C. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-15 · Cited by 104
Yang, J. H., Davies, R. J., Southwood, M. R., Long, L., Yang, X., Sobolewski, A., Upton, P. D., Trembath, R. C., & Morrell, N. W. (2008) · Circulation Research · doi:10.1161/circresaha.108.173567 · Cited by 104
Yang, J. H., Li, X., Al‐Lamki, R. S., Southwood, M. R., Zhao, J., Lever, A. M. L., Grimminger, F., SCHERMULY, R. T., & Morrell, N. W. (2010) · Circulation Research · doi:10.1161/circresaha.109.209940 · Cited by 102
Owens, P., Pickup, M. W., Novitskiy, S. V., Chytil, A., Gorska, A. E., Aakre, M. E., West, J. D., & Moses, H. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101139108 · Cited by 99
Apelin Is a Crucial Factor for Hypoxia-Induced Retinal Angiogenesis
Kasai, A., Ishimaru, Y., Kinjo, T., Satooka, T., Matsumoto, N., Yoshioka, Y., Yamamuro, A., Gomi, F., Shintani, N., Baba, A., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.209775 · Cited by 94
Spiekerkoetter, E. F., Guignabert, C., Pérez, V. D. J., Alastalo, T., Powers, J. M., Wang, L., Lawrie, A., Ambartsumian, N. S., Schmidt, A., Berryman, M. A., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.205120 · Cited by 91
Self-citationMcMurtry, M. S., Bonnet, S., Michelakis, E. D., Bonnet, S. B., Haromy, A., & Archer, S. L. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00310.2006 · Cited by 78
A rapid and sensitive bioassay to measure bone morphogenetic protein activity
Zilberberg, L., ten Dijke, P., Sakai, L. Y., & Rifkin, D. B. (2007) · BMC Cell Biology · doi:10.1186/1471-2121-8-41 · Cited by 77
Complications With Recombinant Human Bone Morphogenic Protein-2 in Posterolateral Spine Fusion
Glassman, S. D., Howard, J. M., Dimar, J. R., Sweet, A., Wilson, G., & Carreon, L. Y. (2010) · Spine · doi:10.1097/brs.0b013e3181d133d0 · Cited by 77
Mechanisms of FK 506–Induced Hypertension in the Rat
Takeda, Y., Miyamori, I., Furukawa, K., Inaba, S., & Mabuchi, H. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.130 · Cited by 69
Ubiquitin-dependent Degradation of Id1 and Id3 is Mediated by the COP9 Signalosome
Berse, M., Bounpheng, M. A., Huang, X., Christy, B. A., Pollmann, C. T., & Dubiel, W. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.08.043 · Cited by 60
Albiñana, V., Sanz-Rodrı́guez, F., Recio-Poveda, L., et al. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.067447 · Cited by 59
Wrana, J. L. (2000) · Science s STKE · doi:10.1126/stke.2000.23.re1 · Cited by 52
Deletion of the eNOS gene has a greater impact on the pulmonary circulation of male than female mice
Miller, A. A., Hislop, A. A., Vallance, P. J., & Haworth, S. G. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00022.2005 · Cited by 46
Emphysema: An Autoimmune Vascular Disease?
Voelkel, N. F., & Taraseviciene-Stewart, L. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200405-033ms · Cited by 44
Hypoxia Regulates Bone Morphogenetic Protein Signaling Through C-Terminal–Binding Protein 1
Wu, X., Chang, M. S., Mitsialis, S. A., & Kourembanas, S. (2006) · Circulation Research · doi:10.1161/01.res.0000237021.65103.24 · Cited by 40
Chen, X., Zankl, A. R., Niroomand, F., Liu, Z., Katus, H. A., Jahn, L., & Tiefenbacher, C. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.03.421 · Cited by 39
Lee, N. Y., Kirkbride, K. C., Sheu, R. D., & Blobe, G. C. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-07-0539 · Cited by 39
Wu, X., Wang, L., Han, Y., Regan, N., Li, P.-K., Villalona, M. A., Hu, X., Briesewitz, R., & Pei, D. (2011) · ACS Combinatorial Science · doi:10.1021/co200057n · Cited by 36
Self-citationPassiatore, G., Gentilella, A., Rom, S., Pacifici, M., Bergonzini, V., & Peruzzi, F. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22505 · Cited by 29
Wijnands, E., Rousch, M., Daemen, M. J. A. P., Tervaert, J. W. C., Biessen, E. A. L., Bai, L., Gabriels, K., & Heeneman, S. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-07-0502 · Cited by 22
Suppression of EGFR Autophosphorylation by FKBP12
Mathea, S., Li, S., Schierhorn, A., Jahreis, G., & Schiene‐Fischer, C. (2011) · Biochemistry · doi:10.1021/bi2013855 · Cited by 20
N‐Acetylcysteine Treatment Protects Against VEGF‐Receptor Blockade‐Related Emphysema
Demura, Y., Tarasevičienė-Stewart, L., Scerbavicius, R., Tuder, R. M., & Voelkel, N. F. (2004) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-120030412 · Cited by 11
Cited by
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Rabinovitch, M., Guignabert, C., Humbert, M., & Nicolls, M. R. (2014) · Circulation Research · doi:10.1161/circresaha.113.301141 · Cited by 1,029
Self-citationPulmonary arterial hypertension: pathogenesis and clinical management
Thenappan, T., Ormiston, M. L., Ryan, J. J., & Archer, S. L. (2018) · BMJ · doi:10.1136/bmj.j5492 · Cited by 998
TGF-β Signaling from Receptors to Smads
Hata, A., & Chen, Y.-G. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022061 · Cited by 888
Signaling Receptors for TGF-β Family Members
Heldin, C.-H., & Moustakas, A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022053 · Cited by 711
Pulmonary Arterial Hypertension
Hassoun, P. M. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2000348 · Cited by 693
Metadata
- Authors
- Spiekerkoetter, E., Tian, X., Cai, J., Hopper, R. K., Sudheendra, D., Li, C. G., El-Bizri, N., Sawada, H., Haghighat, R., Chan, R., Haghighat, L., de Jesus Perez, V., Wang, L., Reddy, S., Zhao, M., Bernstein, D., Solow-Cordero, D. E., Beachy, P. A., Wandless, T. J., ten Dijke, P., & Rabinovitch, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-07-15
- Volume
- 123
- Issue
- 8
- Pages
- 3600-3613
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2134915108
- Cited by
- 449
- References
- 67
- FWCI
- 26.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.